These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8699935

  • 1. Atrial natriuretic peptide increases adrenomedullin in the circulation of healthy humans.
    Vesely DL, Blankenship M, Douglass MA, McCormick MT, Rodriguez-Paz G, Schocken DD.
    Life Sci; 1996; 59(3):243-54. PubMed ID: 8699935
    [Abstract] [Full Text] [Related]

  • 2. Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E2.
    Vesely DL, Perez-Lamboy GI, Schocken DD.
    Life Sci; 2000; 66(10):905-13. PubMed ID: 10714891
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Atrial natriuretic peptides and cyclic guanosine monophosphate metabolism.
    Vesely DL, Giordano AT, Douglass MA, McCormick MT, Rodriguez-Paz G, Schocken DD.
    Am J Med Sci; 1995 Oct; 310(4):143-9. PubMed ID: 7573117
    [Abstract] [Full Text] [Related]

  • 8. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
    Chiou S, Vesely DL.
    Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651
    [Abstract] [Full Text] [Related]

  • 9. Atrial natriuretic peptides increase calcitonin gene-related peptide within human circulation.
    Vesely DL, Overton RM, McCormick MT, Schocken DD.
    Metabolism; 1997 Jul; 46(7):818-25. PubMed ID: 9225838
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Negative feedback of atrial natriuretic peptides.
    Vesely DL, Douglass MA, Dietz JR, Giordano AT, McCormick MT, Rodriguez-Paz G, Schocken DD.
    J Clin Endocrinol Metab; 1994 May; 78(5):1128-34. PubMed ID: 8175968
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Four cardiac hormones increase circulating concentrations of luteinizing hormone and testosterone.
    Vesely DL, San Miguel GI, Hassan I, Gower WR, Schocken DD.
    Endocrine; 2002 Mar; 17(2):145-50. PubMed ID: 12041917
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of CRH, corticotropin, and cortisol.
    Vesely DL, San Miguel GI, Hassan I, Schocken DD.
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4244-9. PubMed ID: 11549655
    [Abstract] [Full Text] [Related]

  • 16. Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of total and tree T4 and free T3 with reciprocal increase in TSH.
    Vesely DL, San Miguel GI, Hassan I, Gower WR, Schocken DD.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5438-42. PubMed ID: 11701719
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intact negative feedback of four cardiac hormones in congestive heart failure.
    Vesely DL, San Miguel GI, Hassan I, Schocken DD.
    Metabolism; 2002 May; 51(5):582-8. PubMed ID: 11979389
    [Abstract] [Full Text] [Related]

  • 20. [N-terminal atrial natriuretic peptides].
    Bełtowski J.
    Postepy Hig Med Dosw; 2000 May; 54(6):895-914. PubMed ID: 11227384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.